HLSE:ORNBVPharmaceuticals
Is Orion Oyj (HLSE:ORNBV) A Bargain On Its New Nivolumab Biosimilar Deal?
Why the new nivolumab biosimilar deal matters for Orion Oyj stock
Orion Oyj (HLSE:ORNBV) has moved into the spotlight after agreeing with Shilpa Medicare’s subsidiary to co develop and supply an intravenous nivolumab biosimilar for Europe as the originator drug approaches loss of exclusivity.
The arrangement gives Orion exclusive rights to register, market, distribute and sell the biosimilar across Europe, while Shilpa Biologicals will lead development and long term manufacturing. The...